Archives

by in
Entry Author Date Location
Merck Scoops Up Idenix in $3.85B Buyout 06/09/14 Boston
Elliott Sigal, Bristol’s Former R&D Chief, on Life After Big Pharma 02/25/14 New York
The Devil is in the Details: What BioPharma Press Releases Don’t Say 04/24/13 Seattle
A Biotech Innovation Supply Chain: Reality or Fantasy? 04/22/13 National
East Coast Life Sciences Roundup: Bristol-Myers, Alnylam, Merck, & More 11/16/12 Boston
Vertex Stays in HepC Game, as All-Oral Combo Passes Small Study 02/23/12 Boston
Will New Business Models Enhance or Endanger Drug Discovery? 02/16/12 National
Vertex Vows to Fight On With Alios Drugs in High-Stakes Hepatitis C Race 01/24/12 Boston
Clarus Ventures Adjusts to Unpredictable Biotech World 01/20/12 Boston
Rempex Raises $67.5M, Vertex Shares Tumble, & More San Diego Life Sciences News 11/10/11 San Diego
Vertex Stock Drops 17% Over Two Days, As Potent Hep C Rivals Emerge 11/08/11 Boston
Page 1 of 1